IKZF1 as a novel marker of minimal residual disease in patients with acute lymphoblastic leukaemia

被引：0
|
作者：
Barkhatov, M. [1 ]
Lebedinova, N. [1 ]
Zagrivnaya, M. [1 ]
Semenova, E. [1 ]
Zubarovskaya, L. [1 ]
Afanasyev, B. [1 ]
机构：
[1] Pavlov State Med Univ St Petersburg, St Petersburg, Russia
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S247 / S248
页数：2
相关论文
共 50 条
  • [1] IKZF1 (IKAROS) deletions as a marker of minimal residual disease in patients with acute leukaemia after alloBMT
    Barkhatov, I.
    Zagrivnaya, M.
    Akimova, A.
    Semenova, E.
    Zubarovskaya, L.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S262 - S263
  • [2] Evaluation Of IKZF1 Δ4-7 Deletion As a Suitable Marker For Minimal Residual Disease Monitoring; A Study Of 161 Consecutive Acute Lymphoblastic Leukaemia (ALL) Patients On The On-Going UKALL14 Trial
    Zareian, Nahid
    Patel, Bella
    Rai-Shetty, Lena
    Rowntree, Clare
    McMillan, Andrew
    Marks, David I.
    Menne, Tobias
    Smith, Paul
    Purnell, Simon
    Micklewright, Lynda
    Moorman, Anthony V.
    Fielding, Adele
    BLOOD, 2013, 122 (21)
  • [3] Minimal residual disease in children with acute lymphoblastic leukaemia
    Catovsky, D
    Farahat, N
    Matutes, E
    Powles, RL
    Pinkerton, CR
    LANCET, 1998, 351 (9111): : 1287 - 1287
  • [4] Impact of IKZF1 Deletions and IKZF1 Plus in Pediatric Acute Lymphoblastic Leukemia Outcome
    Sara Felice, Maria
    Laura Rubio, Patricia
    Ruth Guitter, Myriam
    Gabriel Rossi, Jorge
    Alberto Digiorge, Jorge
    Constanza Guardia, Maria
    Fernandez Barbieri, Maria Angelica
    Gutierrez, Gladys
    Recondo, Ezequiel
    Vides Herrera, Maria Soledad
    Livio, Vanina
    Noemi Alonso, Cristina
    BLOOD, 2018, 132
  • [5] The significance of CRLF2 rearrangements and deletions of IKZF1 in a cohort of adult acute lymphoblastic leukaemia patients
    O'Reilly, John
    Russell, Lisa J.
    Cooney, Julian
    Ensor, Hannah M.
    Purtill, Duncan
    Wright, Matthew
    Moorman, Anthony V.
    CHROMOSOME RESEARCH, 2013, 21 : S108 - S109
  • [6] IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?
    Stanulla, Martin
    Cave, Helene
    Moorman, Anthony, V
    BLOOD, 2020, 135 (04) : 252 - 260
  • [7] Are the Minimal Residual Disease Status and IKZF1 Mutations Play Prognostic Role in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Treated by RALL Protocols?
    Gavrilina, Olga
    Baskhaev, Galina
    Biderman, Bella
    Zarubina, Ksenia
    Troitskaya, Vera
    Sudarikov, Andrey
    Julhakyan, Hunan
    Parovichnikova, Elena
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S268 - S268
  • [8] The Genetic Variants of IKZF1 Gene Linked with the Growing Risk of Childhood Acute Lymphoblastic Leukaemia
    Tayel, Safaa, I
    El-Hefnway, Sally M.
    El-fotoh, Wafaa Moustafa M. Abo
    El-zayat, Rania S.
    CURRENT MOLECULAR MEDICINE, 2019, 19 (01) : 32 - 39
  • [9] Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia
    Waanders, E.
    van der Velden, V. H. J.
    van der Schoot, C. E.
    van Leeuwen, F. N.
    van Reijmersdal, S. V.
    de Haas, V.
    Veerman, A. J.
    van Kessel, A. Geurts
    Hoogerbrugge, P. M.
    Kuiper, R. P.
    van Dongen, J. J. M.
    LEUKEMIA, 2011, 25 (02) : 254 - 258
  • [10] Integrated Use of Minimal Residual Disease Classification and IKZF1 Alteration Status Accurately Predicts 79% of Relapses In Pediatric Acute Lymphoblastic Leukemia
    Waanders, Esme
    van der Velden, Vincent H. J.
    van der Schoot, Ellen
    van Leeuwen, Frank N.
    van Reijmersdal, Simon V.
    de Haas, Valerie
    Veerman, Anjo J.
    van Kessel, Ad Geurts
    Hoogerbrugge, Peter M.
    Kuiper, Roland P.
    van Dongen, Jacques J. M.
    BLOOD, 2010, 116 (21) : 124 - 124
12345